Job Search

Job Title, Keywords, Req ID
Loading...
  • Xencor, Inc., 465 N. Halstead St., Pasadena, CA, USA ● Req #86
    Tuesday, February 11, 2025
    Sr. Manager, Facilities & Engineering Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with cancer and oth ... More
  • Xencor, Inc., 465 N. Halstead St., Pasadena, CA, USA ● Req #87
    Thursday, February 6, 2025
    Scientist 1   Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with cancer and other serious diseases. Mor ... More
  • Xencor, Inc., 465 N. Halstead St., Pasadena, CA, USA ● Req #70
    Tuesday, January 7, 2025
    Sr. Manager, Corporate Communications   Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with cancer and o ... More
  • Xencor San Diego Office, 12770 El Camino Real, San Diego, CA, USA ● Req #74
    Monday, January 6, 2025
    Contract Clinical Trials Master File Coordinator-hybrid San Diego, Ca.   Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patient ... More
  • Xencor San Diego Office, 12770 El Camino Real, San Diego, CA, USA ● Req #95
    Thursday, December 19, 2024
    Temporary Contractor- Contracts Analyst/Manager   Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with ca ... More
  • Xencor San Diego Office, 12770 El Camino Real, San Diego, CA, USA ● Req #88
    Wednesday, November 13, 2024
    Director, Analytical Sciences   Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with cancer and other ser ... More
  • Xencor, Inc., 465 N. Halstead St., Pasadena, CA, USA ● Req #92
    Wednesday, November 13, 2024
    Associate General Counsel, Intellectual Property   Introduction: Xencor is a public, clinical-stage biopharmaceutical company located in the Los Angeles area (Pasadena) and in San Diego. Our focus is developing high-potential XmAb® bispecific T-cell engagers and additional engineered drug candidates that leverage our differentiated technology platforms, and we are advancing our pipeline toward clinical proof-of-concept decisions. Our goal is to create high-impact therapeutics for patients with c ... More